Does BEVACIZUMAB Cause Hyperbilirubinaemia? 211 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 211 reports of Hyperbilirubinaemia have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.3% of all adverse event reports for BEVACIZUMAB.
211
Reports of Hyperbilirubinaemia with BEVACIZUMAB
0.3%
of all BEVACIZUMAB reports
38
Deaths
58
Hospitalizations
How Dangerous Is Hyperbilirubinaemia From BEVACIZUMAB?
Of the 211 reports, 38 (18.0%) resulted in death, 58 (27.5%) required hospitalization, and 23 (10.9%) were considered life-threatening.
Is Hyperbilirubinaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 211 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Hyperbilirubinaemia?
METHOTREXATE (603)
RIBAVIRIN (560)
VINCRISTINE (479)
CYTARABINE (397)
PEGASPARGASE (349)
ACETAMINOPHEN (330)
CYCLOPHOSPHAMIDE (330)
DEXAMETHASONE (315)
CAPECITABINE (279)
SOFOSBUVIR (260)
Which BEVACIZUMAB Alternatives Have Lower Hyperbilirubinaemia Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ